Form 8-K - Current report:
SEC Accession No. 0001193125-26-323753
Filing Date
2026-07-29
Accepted
2026-07-29 16:15:15
Documents
11
Period of Report
2026-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20260724.htm   iXBRL 8-K 56519
2 EX-99.1 adpt-ex99_1.htm EX-99.1 496013
3 GRAPHIC img119828894_0.jpg GRAPHIC 7887
  Complete submission text file 0001193125-26-323753.txt   697229

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20260724.xsd EX-101.SCH 30676
14 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20260724_htm.xml XML 4544
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 261217708
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)